Cell And Gene Therapy Manufacturing Market
Cell And Gene Therapy Manufacturing Market
The cell and gene therapy manufacturing market size is estimated to be USD 5.08 billion in 2024 to reach an estimate of USD 22.88 billion by 2034, at a 16.25% CAGR between 2025 to 2034. The burgeoning biotechnology sector, growing cell and gene therapy research, and increasing investments drive the market.
Report ID: 10013
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 5.08 Bn
Forecast Year,
USD USD 22.88 Bn
CAGR, 2025 -
16.25%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Cell And Gene Therapy Manufacturing Market Size Analysis
Cell And Gene Therapy Manufacturing Market Size By Therapy 2024 to 2034 (USD )
| Therapy | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Allogeneic Cell Therapy | 2794.00 | 3245.10 | 3769.02 | 4377.51 | 5084.23 | 5905.02 | 6858.31 | 7965.47 | 9251.33 | 10744.73 | 12479.17 |
| Autologous Cell Therapy | 2286.00 | 2660.40 | 3096.12 | 3603.22 | 4193.37 | 4880.19 | 5679.49 | 6609.73 | 7692.34 | 8952.28 | 10418.61 |
Cell And Gene Therapy Manufacturing Market Size By Technology 2024 to 2034 (USD )
| Technology | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Somatic Cell Technology | 914.40 | 1057.95 | 1223.98 | 1416.03 | 1638.15 | 1895.04 | 2192.13 | 2535.71 | 2933.03 | 3392.48 | 3923.74 |
| Cell Immortalization Technology | 711.20 | 824.50 | 955.84 | 1108.08 | 1284.56 | 1489.11 | 1726.22 | 2001.04 | 2319.59 | 2688.80 | 3116.73 |
| Viral Vector Technology | 1270.00 | 1475.28 | 1713.74 | 1990.74 | 2312.50 | 2686.26 | 3120.43 | 3624.76 | 4210.59 | 4891.08 | 5681.54 |
| Genome Editing Technology | 762.00 | 886.94 | 1032.37 | 1201.65 | 1398.69 | 1628.04 | 1895.00 | 2205.73 | 2567.43 | 2988.44 | 3478.50 |
| Cell Plasticity Technology | 609.60 | 710.97 | 829.20 | 967.09 | 1127.90 | 1315.45 | 1534.19 | 1789.29 | 2086.81 | 2433.79 | 2838.45 |
| 3D Technology | 812.80 | 949.86 | 1110.01 | 1297.14 | 1515.81 | 1771.31 | 2069.84 | 2418.66 | 2826.23 | 3302.43 | 3858.81 |
Cell And Gene Therapy Manufacturing Market Size By Source 2024 to 2034 (USD )
| Source | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Induced Pluripotent Stem Cells | 1016.00 | 1176.18 | 1361.59 | 1576.18 | 1824.54 | 2111.99 | 2444.65 | 2829.65 | 3275.19 | 3790.79 | 4387.43 |
| Umbilical Cord | 914.40 | 1060.69 | 1230.38 | 1427.20 | 1655.49 | 1920.28 | 2227.41 | 2583.63 | 2996.80 | 3476.01 | 4031.82 |
| Neural Stem | 762.00 | 885.68 | 1029.44 | 1196.53 | 1390.75 | 1616.48 | 1878.86 | 2183.82 | 2538.28 | 2950.26 | 3429.12 |
| Bone Marrow | 1422.40 | 1656.59 | 1929.32 | 2246.97 | 2616.91 | 3047.76 | 3549.54 | 4133.93 | 4814.54 | 5607.19 | 6530.35 |
| Adipose Tissue | 965.20 | 1126.36 | 1314.41 | 1533.85 | 1789.91 | 2088.70 | 2437.35 | 2844.17 | 3318.86 | 3872.76 | 4519.06 |
Cell And Gene Therapy Manufacturing Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Musculoskeletal | 762.00 | 880.54 | 1017.47 | 1175.64 | 1358.32 | 1569.32 | 1812.99 | 2094.40 | 2419.35 | 2794.57 | 3227.81 |
| Cardiovascular | 711.20 | 823.49 | 953.49 | 1103.99 | 1278.20 | 1479.88 | 1713.32 | 1983.55 | 2296.33 | 2658.37 | 3077.41 |
| Gastrointestinal | 457.20 | 530.45 | 615.44 | 714.03 | 828.41 | 961.11 | 1115.05 | 1293.64 | 1500.82 | 1741.16 | 2019.98 |
| Neurological | 812.80 | 944.92 | 1098.51 | 1277.07 | 1484.65 | 1725.98 | 2006.53 | 2332.69 | 2711.86 | 3152.67 | 3665.13 |
| Oncology | 1270.00 | 1479.39 | 1723.30 | 2007.43 | 2338.41 | 2723.95 | 3173.06 | 3696.22 | 4305.63 | 5015.52 | 5842.45 |
| Dermatology | 406.40 | 474.35 | 553.66 | 646.22 | 754.25 | 880.34 | 1027.49 | 1199.23 | 1399.67 | 1633.60 | 1906.61 |
| Others | 660.40 | 772.36 | 903.27 | 1056.35 | 1235.35 | 1444.64 | 1689.35 | 1975.47 | 2310.00 | 2701.12 | 3158.39 |
Cell And Gene Therapy Manufacturing Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1930.40 | 2239.00 | 2596.90 | 3011.95 | 3493.26 | 4051.42 | 4698.68 | 5449.24 | 6319.58 | 7328.77 | 8498.97 |
| Europe | 1422.40 | 1653.11 | 1921.23 | 2232.85 | 2595.00 | 3015.88 | 3505.02 | 4073.48 | 4734.14 | 5501.93 | 6394.24 |
| Asia-Pacific | 1117.60 | 1301.48 | 1515.62 | 1765.00 | 2055.44 | 2393.68 | 2787.59 | 3246.36 | 3780.66 | 4402.92 | 5127.63 |
| Latin America | 355.60 | 414.94 | 484.17 | 564.97 | 659.26 | 769.28 | 897.67 | 1047.50 | 1222.34 | 1426.37 | 1664.48 |
| Middle East & Africa | 254.00 | 296.97 | 347.22 | 405.96 | 474.65 | 554.95 | 648.84 | 758.61 | 886.96 | 1037.01 | 1212.46 |
Cell And Gene Therapy Manufacturing Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
